Interestingly, recent mouse studies indicate that apoE impacts on Aβ plaque initiation since suppression of apoE expression using antisense oligonucleotides (ASOs) in AD transgenic mice reduced plaque load only when delivered prior to plaque onset but had no effect once the plaques were established [165]. This evidence concerns the gene APOE and Alzheimer disease.